LOGIN
Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head
August 2019
Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis
Int J Surg. 2019 Jul 10;69:23-31Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
14 randomized controlled trials were included in this meta-analysis which sought to investigate the impact of autologous bone marrow-derived mesenchymal stem cell (MSC) administration alongside core decompression on outcomes in treatment of patients with osteonecrosis of the femoral head. Pooled analyses of pain scores from 6 months to 2 years, function from 1 to 2 years, and incidence of eventual...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.